Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2026-01-10 @ 12:31 AM
Study NCT ID:
NCT03002220
Status:
COMPLETED
Last Update Posted:
2024-12-11
First Post:
2016-10-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial of Rad-223 Activity in Asymptomatic Patients With mCRPC While on Abiraterone or Enzalutamide Besides AR-V7 Status
Sponsor:
MedSIR
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12-21
Start Date Type:
ACTUAL
Primary Completion Date:
2020-05-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-09
Completion Date Type:
ACTUAL
First Submit Date:
2016-10-20
First Submit QC Date:
None
Study First Post Date:
2016-12-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-03-30
Results First Submit QC Date:
None
Results First Post Date:
2024-12-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-09
Last Update Post Date:
2024-12-11
Last Update Post Date Type:
ACTUAL